Capua BioServices has announced the completion of the renovation of one of the recovery and purification plants, at its facility in Capua, Italy.
In order to continuously add value to its growing customer base, Capua BioServices has designed its entire facility to be flexible; from lab - to development - to commercial production scale. This specific investment to renew this existing plant, is focused on further increasing its multi-purpose manufacturing capabilities for pharma-grade manufacturing. The strength of this new set up is that it can be used to process - via an integrated modular tangential-flow-filtration system - serval thousands of liters to tens of thousands of liters in a very time- and space-efficient manner, still leaving further room for expansion.
"We are very happy that our shareholder, Livia Group, is supporting our investment in this field. There is a strong commitment from us to increasingly support the developers of advanced therapies throughout the dynamics of clinical development, while navigating towards seamless transition to commercial production," said Sabine Decker, Chief Operating Officer of Capua BioServices. "We are convinced that with this refurbishment and expansion of this installation which will house a large diversity of unit operations, we can provide a broader offer to our customers and assist them to rapidly deliver clinical candidates to patients."